• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Neurological Adverse Events Determine Morbidity and Mortality Post Allogeneic Hematopoietic Cell Transplantation
Conclusions: Our large retrospective study highlights the wide spectrum of manifestations and etiologies of neurological complications in alloHCT recipients. Prompt diagnosis is required for adequate management, a major of determinant of survival. Thus, long-term increased awareness and collaboration between expert physicians is warranted to improve patient outcomes.Figure.DisclosuresGavriilaki: European Hematology Association: Research Funding. Vardi: Janssen: Honoraria; Gilead: Research Funding.
Source: Blood - November 21, 2018 Category: Hematology Authors: Sakellari, I., Gavriilaki, E., Papagiannopoulos, S., Gavriilaki, M., Batsis, I., Mallouri, D., Vardi, A., Constantinou, V., Iskas, M., Masmanidou, M., Yannaki, E., Geroukis, T., Kazis, D., Kimiskidis, V., Anagnostopoulos, A. Tags: 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence Source Type: research

Neurological complications in renal transplant patients: A single-center experience
Conclusion We conclude that complications involving the neurological system occur in 10.5% of all transplant patients with 8% involving CNS and 7% involving the PNS. The high mortality rates associated with CNS complications warrant early diagnosis and aggressive treatment in renal transplant recipients.
Source: Indian Journal of Transplantation - November 24, 2015 Category: Transplant Surgery Source Type: research